Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.
Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R. Maffei R, et al. Among authors: santachiara r. Blood. 2010 Jul 29;116(4):584-92. doi: 10.1182/blood-2009-11-252494. Epub 2010 Apr 9. Blood. 2010. PMID: 20382847 Free article.
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide.
Maffei R, Fiorcari S, Martinelli S, Benatti S, Bulgarelli J, Rizzotto L, Debbia G, Santachiara R, Rigolin GM, Forconi F, Rossi D, Laurenti L, Palumbo GA, Vallisa D, Cuneo A, Gaidano G, Luppi M, Marasca R. Maffei R, et al. Among authors: santachiara r. Leuk Lymphoma. 2018 Feb;59(2):423-433. doi: 10.1080/10428194.2017.1339872. Epub 2017 Jun 22. Leuk Lymphoma. 2018. PMID: 28639485 Clinical Trial.
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
Maffei R, Fiorcari S, Bulgarelli J, Rizzotto L, Martinelli S, Rigolin GM, Debbia G, Castelli I, Bonacorsi G, Santachiara R, Forconi F, Rossi D, Laurenti L, Palumbo GA, Vallisa D, Cuneo A, Gaidano G, Luppi M, Marasca R. Maffei R, et al. Among authors: santachiara r. Exp Hematol. 2014 Feb;42(2):126-36.e1. doi: 10.1016/j.exphem.2013.10.007. Epub 2013 Nov 6. Exp Hematol. 2014. PMID: 24212063 Free article. Clinical Trial.
Pregnancy in PNH: another eculizumab baby.
Marasca R, Coluccio V, Santachiara R, Leonardi G, Torelli G, Notaro R, Luzzatto L. Marasca R, et al. Among authors: santachiara r. Br J Haematol. 2010 Sep;150(6):707-8. doi: 10.1111/j.1365-2141.2010.08258.x. Br J Haematol. 2010. PMID: 20553271 Free article. No abstract available.
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status.
Maffei R, Marasca R, Martinelli S, Castelli I, Santachiara R, Morandi E, Zucchini P, Fontana M, Giacobbi F, Silingardi P, Bonacorsi G, Temperani P, Masini L, Colacci AM, Serra R, Torelli G. Maffei R, et al. Among authors: santachiara r. Leukemia. 2007 Jun;21(6):1312-5. doi: 10.1038/sj.leu.2404650. Epub 2007 Mar 15. Leukemia. 2007. PMID: 17361220 No abstract available.
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, Forconi F, Spina V, Cencini E, Drandi D, Ladetto M, Santachiara R, Marasca R, Gattei V, Cavalli F, Zucca E, Gaidano G, Bertoni F. Rinaldi A, et al. Among authors: santachiara r. Br J Haematol. 2011 Sep;154(5):590-9. doi: 10.1111/j.1365-2141.2011.08789.x. Epub 2011 Jul 12. Br J Haematol. 2011. PMID: 21749360 Free article.
16 results